Načítá se...
PCI in Patients with Diabetes: Role of the Cre8 Drug-eluting Stent
Patients with diabetes have poor outcomes compared to the general patient population when undergoing percutaneous coronary intervention. The Cre8™ (Alvimedica) drug-eluting stent (DES) has unique features that may improve clinical outcomes in patients with diabetes. These include abluminal reservoir...
Uloženo v:
| Vydáno v: | Interv Cardiol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Radcliffe Cardiology
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5808482/ https://ncbi.nlm.nih.gov/pubmed/29588724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/icr.2016:28:2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|